pulsed field ablation - search results
If you're not happy with the results, please do another search
Medtronic completes enrolment in pulsed field ablation catheter trial for patients with AF
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....
First patients treated in study of Globe pulsed field ablation system
Kardium has announced the successful first-in-human study of its next generation Globe pulsed field system to treat atrial fibrillation (AF) using pulsed field ablation...
AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal...
AtriAN Medical has announced that it has completed enrolment of a second study using its selective pulsed field ablation (PFA) technology for the treatment...
Study shares success of complete PVI using only pulsed field ablation
A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...
Pulsed field ablation poised to revolutionise the treatment of atrial fibrillation
The advent of pulsed field ablation (PFA) will revolutionise the treatment of atrial fibrillation (AF), Tom de Potter (Aalst, Belgium) tells Cardiac Rhythm News,...
First patients treated in ADVENT trial of pulsed field ablation system
FARAPULSE has announced that the first patients have been treated in the ADVENT trial, a US Food and Drug Administration (FDA) Investigational Device Exemption...
Farapulse gains CE mark for its pulsed field ablation system
Farapulse announced that it has received the CE mark for its pulsed field ablation (PFA) system for the treatment of paroxysmal atrial fibrillation (AF)....
Boston Scientific to invest in pulsed field ablation device developer
Boston Scientific has signed an investment agreement with an exclusive option to acquire Farapulse, a privately-held company developing a pulsed field ablation (PFA) system...
Adagio Medical reports pre-clinical success combining cryoablation catheter with pulsed field ablation
Adagio Medical, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced successful pre-clinical results demonstrating its existing cryoablation catheter is also capable...
AF Symposium 2020: Myocardial specificity of pulsed field ablation provides safety advantage for persistent...
At the AF Symposium 2020 (23–25 January, Washington, DC, USA), Vivek Y Reddy (Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, USA)...
First patients treated using Adagio Medical’s pulsed field cryoablation system
Adagio Medical has announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF).
The cases were performed at Medicover Hospital,...
Single-shot pulsed-field ablation yields “excellent” PVI durability
Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...
Galaxy Medical and Japan Lifeline enter distribution agreement for pulsed electric field focal ablation...
Galaxy Medical (Galaxy) and Japan Lifeline (JLL) have announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the USA, developed by Japan...
First patients treated in Kardium PULSAR IDE study of Globe pulsed field system
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
Medtronic receives CE Mark approval for Affera mapping and ablation system to treat arrhythmias
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...
Dual energy AF ablation catheter begins evaluation in SmartfIRE clinical trial
Biosense Webster has announced the first cases with its investigational Thermocool Smarttouch SF dual energy catheter have taken place as part of the SmartfIRE...
ACC 2023: Pulsed AF trial yields “promising” safety and efficacy results for PFA system
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation (PFA) treatment in patients with paroxysmal and persistent atrial fibrillation (AF), have been...
Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy
Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...
Centauri pulsed electric field system gains CE mark approval
Galaxy Medical has announced that it received the CE mark for its Centauri pulsed electric field (PEF) system and launched its commercial programme.
The approval...
AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies shared
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
Kardium secures financing to advance Globe mapping and ablation system
Kardium has raised US$115 million in a new financing round, which will be used to accelerate commercial growth of the Globe mapping and ablation...
First patients treated with the Centauri pulsed electric field system
Galaxy Medical, a developer of pulsed electric field (PEF) technology, has announced that the first patients in the ECLIPSE-AF study were successfully treated with...
Results of PULSED AF trial presented at HRS 2020 Science
Initial results of the PULSED AF trial, the first-in-human results for paroxysmal or persistent atrial fibrillation (AF) treated with pulsed field ablation (PFA) were...
AF Symposium 2020: Cryoablation pulmonary vein isolation is safe and effective for persistent atrial...
Hugh Calkins (Johns Hopkins Medical Institutions, Baltimore, USA) told delegates attending the AF Symposium 2020 (23–25 January, Washington, DC, USA) that cryoablation with the...
AF Symposium hears late-breaking data from RFA and PFA trials
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
Adagio Medical announces patient enrolment in PARALELL trial
Adagio Medical has announced its first pulsed field cryoablation (PFCA) procedure performed using the Adagio CryoPulse catheter system as part of the PARALELL (Pulsed...
Medtronic adds cardiac mapping platform through Affera acquisition
Medtronic has announced that it has completed the acquisition of Affera. The acquisition will expand Medtronic’s cardiac ablation portfolio to include its first cardiac...
Thromboembolic cerebral events ‘rare’ in patients undergoing PFA
In patients treated with pulsed field ablation (PFA) for symptomatic paroxysmal atrial fibrillation (AF), the incidence of asymptomatic thromboembolic cerebral events or lesions detected...
Medtronic to acquire Affera
Medtronic has announced that it has entered into an agreement to acquire medical technology company Affera.
Affera designs and manufactures cardiac mapping and navigation systems...
First patient treated in SPHERE PerAF trial
Affera has announced that the first patient was treated in the recently approved SPHERE PerAF trial, a US Food and Drug Administration (FDA) Investigational...
First-in-man procedures performed with Globe PFA system
Kardium has announced the completion of successful first-in-human (FIH) procedures with the Globe pulsed field system.
Vivek Reddy of Mount Sinai Hospital (New York, USA)...
AcQForce PFA-CE study begins for focal PFA therapy to treat atrial fibrillation
Acutus Medical has announced the initiation of AcQForce PFA-CE, a clinical study that will evaluate the safety and performance of the company’s focal force...
ESC 2021: Initial data from inspIRE clinical trial released
Biosense Webster, part of the Johnson & Johnson Medical Devices Companies, has announced the presentation of data from the inspIRE clinical trial at the...
Affera’s SpherePVI gets first-in-human use
Affera has announced the first-in-human use of its circumferential pulmonary vein isolation (PVI) pulsed field ablation (PFA) catheter, SpherePVI.
The work was conducted as part...
Boston acquires remaining shares of Farapulse
Boston Scientific has exercised its option to acquire the remaining shares of Farapulse. The acquisition will complement the existing Boston Scientific electrophysiology portfolio to...
First procedures performed in pivotal trial to evaluate PulseSelect PFA system
Medtronic has announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect pulsed field ablation (PFA) system, a...
Adagio closes US$42.5 million Series E financing
Adagio, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced that it has closed a US$42.5 million Series E equity financing. Proceeds...
First patients in Europe treated with Biosense Webster Varipulse catheter
Johnson & Johnson has announced that Biosense Webster has enrolled and treated the first patients in its inspIRE clinical study in Europe. The study...
Acutus announces pre-clinical results of a novel diagnostic workflow using its AcQMap system
Acutus Medical has announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilising the AcQMap system along with tissue-selective, non-thermal pulse field...
Medtronic gains FDA approval for PulseSelect trial
Medtronic has received approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the...
Leading electrophysiologists identify four key studies that will shape arrhythmia treatment in 2020
Leading electrophysiologists have pinpointed four clinical studies due to report findings in 2020—AMULET IDE, aMAZE IDE, PULSED AF and CEASE AF—that they expect to...
Study reveals low reconnection rate with large antral lesion at PW after pentaspline PFA...
A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...
AtriAN Medical present results of Neural AF trial at AF Symposium 2022
According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...
First patients enrolled in SPACE-AF study
Galaxy Medical announced today the initiation of the SPACE-AF study with enrolment of the first two patients at Southlake Regional Health Centre in Newmarket,...
AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF
Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...
AF Symposium 2021: Live case from ECLIPSE-AF study to feature
Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac arrhythmias, has announced that the proprietary Centauri system will...
